International Clinical Trial: A prospective, single-center, single-arm study to evaluate the efficacy and safety of imetelstat in adults with severe alopecia areata refractory to systemic therapy

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117015) titled 'A prospective, single-center, single-arm study to evaluate the efficacy and safety of imetelstat in adults with severe alopecia areata refractory to systemic therapy' on Jan. 19.

Study Type: Interventional study

Study Design: Non randomized control

Primary Sponsor: Affiliated Hospital of Guilin Medical University

Condition: Alopecia Areata, AA

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-24

Target Sample Size: Trial group:32;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=305786

Disclaimer: Curated by HT Syndicatio...